bexotegrast
bexotegrast: sourced relationships with 1 company · 3 clinical trials tracked.
bexotegrast evidence translation
What we can confirm
3 tracked trials
What it means
What to watch
Prepared research question
How could bexotegrast → PLRX affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence4 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (2)
| Company | Dated record stage |
|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) Primary Sclerosing Cholangitis (PSC) | Phase 2 |
| PLIANT THERAPEUTICS, INC. (PLRX) Idiopathic Pulmonary Fibrosis; Primary Sclerosing Cholangiti… | Phase 2 |
Clinical Trial Registry Records (3)
A Randomized, Double-blind, Dose-ranging, Placebo-controlled Study to Evaluate the Efficacy and Safety of Bexotegrast (PLN-74809) for the Treatment of Idiopathic Pulmonary Fibrosis (BEACON-IPF)
Primary endpoint: Change From Baseline in Forced Vital Capacity at Week 52
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Evaluation of PLN-74809 on Type 1 Collagen Deposition Using 68Ga-CBP8 PET/MRI Imaging in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Primary endpoint: Primary Outcome
A Randomized, Double-blind, Dose-ranging, Placebo-controlled, Phase 2a Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Primary Sclerosing Cholangitis (PSC) and Suspected Liver Fibrosis (INTEGRIS-PSC)
Primary endpoint: Number of Participants With Treatment Emergent Adverse Events
Frequently asked questions
Which companies have sourced relationships with bexotegrast?
bexotegrast has dated SEC/FDA relationship records for PLIANT THERAPEUTICS, INC..
How many clinical trials involve bexotegrast?
BioSniper tracks 3 clinical trials involving bexotegrast.